Category Health

European regulators initially said in July that the drug’s benefits did not outweigh its risks. European regulators have recommended granting marketing authorisation for the Alzheimer’s drug lecanemab after an initial negative opinion earlier this year. Lecanemab, marketed as Leqembi, is…

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Here’s our process. Here’s our process Medical News Today only shows you brands and products that…